David Devos

Best Publications

• Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.

  Bruce Do Van;Flore Gouel;Aurélie Jonneaux;Kelly Timmerman

  690
  Citations

• Colonic inflammation in Parkinson's disease.

  David Devos;Thibaud Lebouvier;Bernard Lardeux;Bernard Lardeux;Mandy Biraud

  626
  Citations

• The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease

  P Sockeel;K Dujardin;D Devos;C Denève

  618
  Citations

• Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.

  Laura Mahoney-Sánchez;Hind Bouchaoui;Scott Ayton;David Devos

  511
  Citations

• Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

  Shashank Masaldan;Ashley I Bush;David Devos;Anne Sophie Rolland

  448
  Citations

• STN-DBS frequency effects on freezing of gait in advanced Parkinson disease

  C. Moreau;L. Defebvre;A. Destée;S. Bleuse

  415
  Citations

• Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

  David Devos;Kathy Dujardin;Isabelle Poirot;Caroline Moreau

  339
  Citations

• Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

  Yi Wang;Yi Wang;Pascal Spincemaille;Zhe Liu;Zhe Liu;Alexey Dimov;Alexey Dimov

  291
  Citations

• Characteristics of apathy in Parkinson's disease

  Kathy Dujardin;Pascal Sockeel;David Devos;Marie Delliaux

  285
  Citations

• Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.

  David Devos

  251
  Citations

• Trial of Deferiprone in Parkinson's Disease.

  Unknown

  241
  Citations

• Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

  Caroline Moreau;Arnaud Delval;Luc Defebvre;Kathy Dujardin

  234
  Citations

• Elevated IL-6 and TNF-α levels in patients with ALS : Inflammation or hypoxia?

  C. Moreau;D. Devos;V. Brunaud-Danel;L. Defebvre

  192
  Citations

• Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

  David Devos;Caroline Moreau;David Maltête;Romain Lefaucheur

  185
  Citations

• Brief and sustained movements: differences in event-related (de)synchronization (ERD/ERS) patterns.

  François Cassim;William Szurhaj;Haouaria Sediri;David Devos

  181
  Citations

• Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease

  D Devos;P Krystkowiak;F Clement;K Dujardin

  176
  Citations

• A specific clinical pattern of camptocormia in Parkinson’s disease

  AC Lepoutre;D Devos;A Blanchard-Dauphin;V Pardessus

  168
  Citations

• Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.

  Nicolas Carriere;Pierre Besson;Kathy Dujardin;Alain Duhamel

  164
  Citations

• Low levels of the vascular endothelial growth factor in CSF from early ALS patients.

  D. Devos;C. Moreau;P. Lassalle;T. Perez

  163
  Citations

• Heart rate variability and Parkinson's disease severity.

  D Devos;M Kroumova;R Bordet;H Vodougnon

  155
  Citations

• 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis.

  Hélène Blasco;Hélène Blasco;Philippe Corcia;Philippe Corcia;Caroline Moreau;Ségolène Veau

  141
  Citations